Literature DB >> 32619833

How antibiotics work together: molecular mechanisms behind combination therapy.

Geraldine J Sullivan1, Natasha N Delgado1, Ram Maharjan1, Amy K Cain2.   

Abstract

Antibiotics used in combination are an effective strategy for combatting numerous infectious diseases in clinical and veterinary settings, particularly as a last-line therapy for difficult-to-treat cases. Combination therapy can either increase or slow the rate of killing, broaden the antibiotic spectrum, reduce dosage and unwanted side-effects, and even control the emergence of resistance. The administration of antibiotics in combination has been used effectively against bacterial infections for >70 years, first used to treat tuberculosis. However, effective antibiotic combinations and their dosage regimes have been largely determined empirically in the clinic, and the molecular mechanisms underpinning how these combinations work remains surprisingly elusive. This review focuses on studies that have outlined the genetics and molecular mechanisms of action underlying antibiotic combinations, as well as those that examine how resistance develops. We highlight the need for further experimentation and genetic validation to fully realise the potential of combination therapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32619833     DOI: 10.1016/j.mib.2020.05.012

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  7 in total

Review 1.  Leveraging laboratory and clinical studies to design effective antibiotic combination therapy.

Authors:  Kathleen Davis; Talia Greenstein; Roberto Viau Colindres; Bree B Aldridge
Journal:  Curr Opin Microbiol       Date:  2021-10-08       Impact factor: 7.934

2.  Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli.

Authors:  Amit Gaurav; Varsha Gupta; Sandeep K Shrivastava; Ranjana Pathania
Journal:  Commun Biol       Date:  2021-05-10

3.  Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Ozioma F Nwabor; Pawarisa Terbtothakun; Supayang P Voravuthikunchai; Sarunyou Chusri
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25

4.  Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.

Authors:  Luísa V Zacharias; Natália C Moreira; Nathália Abichabki; Fernando Bellissimo-Rodrigues; Fernanda L Moreira; Jhohann R L Benzi; Tânia M C Ogasawara; Joseane C Ferreira; Camila M Ribeiro; Fernando R Pavan; Leonardo R L Pereira; Guilherme T P Brancini; Gilberto Ú L Braga; Antonio W Zuardi; Jaime E C Hallak; José A S Crippa; Vera L Lanchote; Rafael Cantón; Ana Lúcia C Darini; Leonardo N Andrade
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

5.  In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.

Authors:  Yong Guk Ju; Hak Joon Lee; Hong Soon Yim; Min-Goo Lee; Jang Wook Sohn; Young Kyung Yoon
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

6.  Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Xinqian Ma; Shining Fu; Yifan Wang; Lili Zhao; Wenyi Yu; Yukun He; Wentao Ni; Zhancheng Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

Review 7.  Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa.

Authors:  Haoran Li; Mireguli Maimaitiming; Yue Zhou; Huaxuan Li; Pingyuan Wang; Yang Liu; Till F Schäberle; Zhiqing Liu; Chang-Yun Wang
Journal:  Mar Drugs       Date:  2022-03-04       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.